Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves new doses of Advancis’ antibiotic
The new Keflex (cephalexin) 750mg strength provides healthcare professionals a more convenient way to deliver a total daily dose of 1500mg per day, through the ability to use
The new Keflex (cephalexin) 750mg strength provides healthcare professionals a more convenient way to deliver a total daily dose of 1500mg per day, through the ability to use
The rights Inovio has licensed include two patents with broad claims regarding electroporation of nucleic acids in muscle and tumor tissue. The license also includes grants of rights
The compound used in the research is a surrogate of eculizumab, Alexion's lead anti-compliment antibody. The study shows that anti-C5 monoclonal antibodies, including eculizumab, can be successfully aerosolized
The study sites include the Dana-Farber Cancer Institute, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center and will be conducted under the direction of Dr Matthew Kulke.
Barr, which markets its line of isotretinoin capsules under the tradename Claravis, will launch the new dosage strength immediately. The 30mg dose capsule will now join the 10mg,
The researchers were encouraged after a finding that a new chemotherapy drug works best in patients who have no expression of a specific genetic alteration. Research programs at
Chantix' approval was based on a comprehensive clinical trial program including four pivotal trials involving more than 2,000 cigarette smokers. Subjects on average had smoked about 21 cigarettes
By combining data from nine randomized clinical trials and evaluating clinical outcomes individually rather than in combination, the analysis was able to put a sharper focus on the
“Boston Scientific is excited to distribute this next-generation bulking agent,” said Eric Goorno, president of the urology and gynecology businesses at Boston Scientific. “This agent is designed to
Under terms of the agreement, Clinical Data’s PGxHealth division will provide Duke University’s Institute for Genome Sciences & Policy (IGSP) with non-exclusive access to its studies conducted to